Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Long-term and Short-term Efficacy and Safety of Transplantation Autologous Bone Marrow Cells (BMCs) in Patients With the First STEMI (ST Segment Elevation Myocardial Infarction) (ESTABOMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01748383
Recruitment Status : Unknown
Verified December 2012 by Vyacheslav Ryabov, Russian Academy of Medical Sciences.
Recruitment status was:  Active, not recruiting
First Posted : December 12, 2012
Last Update Posted : December 17, 2012
Sponsor:
Information provided by (Responsible Party):
Vyacheslav Ryabov, Russian Academy of Medical Sciences

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2013
Estimated Study Completion Date : September 2014
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 December 10, 2016
February 2, 2017
2 March 2, 2017
April 12, 2017
3 April 17, 2017
July 13, 2017